Clinical Trial Update: Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial studying autologous implantation of mesenchymal stem cells for distal tibial fractures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Tibial Fracture
• Tibial Fracture

Drugs mentioned

• Autologous mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Tibial Fracture | Phase 1, Phase 2 | Status: COMPLETED